In vitro safety and anti-bacterial efficacy assessment of acriflavine
Allergy
.
2022 Jun;77(6):1917-1920.
doi: 10.1111/all.15289.
Epub 2022 Mar 31.
Authors
Shari Javadiyan
1
2
,
Kitty C Germein
1
2
,
Clare M Cooksley
1
2
,
Mahnaz Ramezanpour
1
2
,
Narinder Singh
3
4
,
Peter-John Wormald
1
2
,
Sarah Vreugde
1
2
,
Alkis J Psaltis
1
2
Affiliations
1
Department of Otolaryngology Head and Neck Surgery, University of Adelaide, Adelaide, SA, Australia.
2
Basil Hetzel Institute for Translational Health Research, Central Adelaide Local Health Network, Adelaide, SA, Australia.
3
Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
4
Department of Otolaryngology, Head & Neck Surgery, Westmead Hospital, Sydney, NSW, Australia.
PMID:
35322438
PMCID:
PMC9311691
DOI:
10.1111/all.15289
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Acriflavine*
Anti-Bacterial Agents* / adverse effects
Bacteria
Humans
Substances
Anti-Bacterial Agents
Acriflavine